- Kathleen Sebelius cites pharmacists' importance as Rite Aid CEO introduces Obamacare resource program
- Senate passes Drug Quality and Security Act
- New Rite Aid group VP pharmacy initiatives and clinical services to oversee Wellness Ambassador program
- NACDS, NCPA, GPhA express support for Drug Quality and Security Act
- NCPA: Community pharmacy has historically helped patients as they transition to new health plans
CAMP HILL, Pa. — Rite Aid's same-store sales decreased by 1.5% in May as the shift to generic drugs continued to offset front-end comps, the retail pharmacy chain said Thursday.
The Camp Hill, Pa.-based retailer reported a 0.8% increase in front-end comps for the month, which included the five weeks that ended June 1, and a 2.7% decrease in pharmacy comps, which itself included a 3.73% negative effect from new generics. Same-store prescription count decreased by 0.3%.
Total-store sales for the month were $2.423 billion, a 1.5% decreased from May 2012's $2.459 billion, with 67% of sales coming from sales of prescription drugs.
For the 13-week period that ended June 1, comps decreased by 2.5%, including a 0.4% increase in front-end comps and a 3.8% decrease in pharmacy comps. Same-store prescription count decreased by 0.1%. Total-store sales for the period were $6.264 billion, a 2.8% decrease from last May's $6.441 billion.